{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:32:22Z","timestamp":1777566742231,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G079614N, G059713N"],"award-info":[{"award-number":["G079614N, G059713N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["100013"],"award-info":[{"award-number":["100013"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01324","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T04:56:03Z","timestamp":1509512163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads"],"prefix":"10.3389","volume":"8","author":[{"given":"Chandra S.","family":"Chirumamilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Palagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balu","family":"Kamaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Declerck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinus W. C.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryabtsova","family":"Oksana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolien","family":"De Bosscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Bougarne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Ruttens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Houtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnok H.","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgen","family":"Joossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Van Der Veken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Augustyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xaveer","family":"Van Ostade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemie","family":"Bogaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"De Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Vanden Berghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci (Lond)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1210\/er.2014-1010","article-title":"Comprehensive overview of the structure and regulation of the glucocorticoid receptor","volume":"35","author":"Vandevyver","year":"2014","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"De Bosscher","year":"2003","journal-title":"Endocr Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mce.2012.12.014","article-title":"How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering","volume":"380","author":"Ratman","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1600-0625.2006.00453.x","article-title":"Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index","volume":"15","author":"Schacke","year":"2006","journal-title":"Exp Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1073\/pnas.0300372101","article-title":"Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects","volume":"101","author":"Schacke","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mce.2007.05.014","article-title":"Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index","volume":"275","author":"Schacke","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0026-895X(24)12543-6","article-title":"Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism","volume":"56","author":"Vanden Berghe","year":"1999","journal-title":"Mol Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1124\/mol.107.038794","article-title":"Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?","volume":"72","author":"Newton","year":"2007","journal-title":"Mol Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1038\/ncomms8796","article-title":"Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1","volume":"6","author":"Vettorazzi","year":"2015","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1172\/JCI88886","article-title":"Glucocorticoid receptors: finding the middle ground","volume":"127","author":"Desmet","year":"2017","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","article-title":"DNA binding of the glucocorticoid receptor is not essential for survival","volume":"93","author":"Reichardt","year":"1998","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2015.09.002","article-title":"Activation of the glucocorticoid receptor in acute inflammation: the SEDIGRAM concept","volume":"37","author":"De Bosscher","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1016\/j.bmcl.2016.08.091","article-title":"Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition","volume":"26","author":"Ryabtsova","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1016\/j.bmcl.2008.10.021","article-title":"The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist","volume":"18","author":"Madauss","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4939-1346-6_8","article-title":"Cofactor profiling of the glucocorticoid receptor from a cellular environment","volume":"1204","author":"Desmet","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1210\/en.2015-1390","article-title":"A mixed glucocorticoid\/mineralocorticoid selective modulator with dominant antagonism in the male rat brain","volume":"156","author":"Atucha","year":"2015","journal-title":"Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"18114","DOI":"10.1073\/pnas.0909125106","article-title":"Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor","volume":"106","author":"Biggadike","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/jm401616g","article-title":"Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design","volume":"57","author":"Carson","year":"2014","journal-title":"J Med Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.05.001","article-title":"Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds","volume":"152","author":"Sundahl","year":"2015","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/1871528113666141106101356","article-title":"Mapracorat, a novel non-steroidal selective glucocorticoid receptor agonist for the treatment of allergic conjunctivitis","volume":"13","author":"Baiula","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"B22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bcpt.12621","article-title":"Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD5423 after inhalation in healthy volunteers","volume":"119","author":"Werkstrom","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1073\/pnas.78.6.3541","article-title":"Dexamethasone 21-mesylate: an affinity label of glucocorticoid receptors from rat hepatoma tissue culture cells","volume":"78","author":"Simons","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","first-page":"2244s","article-title":"Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells","volume":"49","author":"Simons","year":"1989","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2174\/092986711796391705","article-title":"Irreversible protein kinase inhibitors","volume":"18","author":"Garuti","year":"2011","journal-title":"Curr Med Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"B27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chembiol.2012.12.006","article-title":"Developing irreversible inhibitors of the protein kinase cysteinome","volume":"20","author":"Liu","year":"2013","journal-title":"Chem Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","article-title":"Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies","volume":"20","author":"Bauer","year":"2015","journal-title":"Drug Discov Today"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acsmedchemlett.5b00475","article-title":"Hope and disappointment: covalent inhibitors to overcome drug resistance in non-small cell lung cancer","volume":"7","author":"Engel","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"B30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.phrs.2016.09.011","article-title":"Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms","volume":"113","author":"Roskoski","year":"2016","journal-title":"Pharmacol Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/sj.leu.2404528","article-title":"Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma","volume":"21","author":"Bonvini","year":"2007","journal-title":"Leukemia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/DDDT.S15850","article-title":"Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer","volume":"6","author":"Rehman","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"B34","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.4049\/jimmunol.148.9.2785","article-title":"Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis","volume":"148","author":"Vanhaesebroeck","year":"1992","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden Berghe","year":"1998","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/emboj.2008.95","article-title":"Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition","volume":"27","author":"Beck","year":"2008","journal-title":"EMBO J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.2910170110","article-title":"A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells","volume":"17","author":"Lieber","year":"1976","journal-title":"Int J Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15827","DOI":"10.1073\/pnas.0505554102","article-title":"A fully dissociated compound of plant origin for inflammatory gene repression","volume":"102","author":"De Bosscher","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/cyto.a.20807","article-title":"High content image cytometry in the context of subnuclear organization","volume":"77","author":"De Vos","year":"2010","journal-title":"Cytometry A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0170688","DOI":"10.1371\/journal.pone.0170688","article-title":"Accurate detection of dysmorphic nuclei using dynamic programming and supervised classification","volume":"12","author":"Verschuuren","year":"2017","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2016.1247144","article-title":"Deregulation of focal adhesion formation and cytoskeletal tension due to loss of A-type lamins","author":"Corne","year":"2016","journal-title":"Cell Adh Migr"},{"key":"B42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/pmic.200900409","article-title":"ms_lims, a simple yet powerful open source laboratory information management system for MS-driven proteomics","volume":"10","author":"Helsens","year":"2010","journal-title":"Proteomics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Berk","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Schuttelkopf","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1021\/ja00119a045","article-title":"Molecular dynamics simulations on solvated biomolecular systems: the particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins","volume":"117","author":"Cheatham","year":"1995","journal-title":"J Am Chem Soc"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/me.2007-0219","article-title":"Glucocorticoid receptor phosphorylation differentially affects target gene expression","volume":"22","author":"Chen","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mce.2010.06.007","article-title":"Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity","volume":"327","author":"Avenant","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B51","doi-asserted-by":"crossref","first-page":"9676","DOI":"10.1016\/S0021-9258(18)47987-2","article-title":"Identification of cysteine 656 as the amino acid of hepatoma tissue culture cell glucocorticoid receptors that is covalently labeled by dexamethasone 21-mesylate","volume":"262","author":"Simons","year":"1987","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"D364","DOI":"10.1093\/nar\/gku1028","article-title":"A series of PDB-related databanks for everyday needs","volume":"43","author":"Touw","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids \u2013 new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.14573\/altex.2013.2.145","article-title":"A 155-plex high-throughput in vitro coregulator binding assay for (anti-)estrogenicity testing evaluated with 23 reference compounds","volume":"30","author":"Wang","year":"2013","journal-title":"ALTEX"},{"key":"B56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.1164265","article-title":"DNA binding site sequence directs glucocorticoid receptor structure and activity","volume":"324","author":"Meijsing","year":"2009","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/dmd.111.039099","article-title":"Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys","volume":"39","author":"Proksch","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1167\/iovs.10-5598","article-title":"In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease","volume":"52","author":"Shafiee","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejphar.2013.05.035","article-title":"Anti-inflammatory glucocorticoids: changing concepts","volume":"724","author":"Newton","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/vde.12315","article-title":"The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs","volume":"28","author":"Baumer","year":"2017","journal-title":"Vet Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ncpendmet0745","article-title":"Drug insight: selective agonists and antagonists of the glucocorticoid receptor","volume":"4","author":"Mcmaster","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1476-5381.2009.00238.x","article-title":"Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases","volume":"158","author":"Schacke","year":"2009","journal-title":"Br J Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01324\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T20:34:30Z","timestamp":1750970070000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01324\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2017.01324"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01324","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"article-number":"1324"}}